Development of a novel composite process measure for venous thromboembolism prophylaxis

Christine V. Kinnier, Mila H. Ju, Thomas Kmiecik, Cindy Barnard, Terri Halverson, Anthony D. Yang, Joseph Caprini, Lindsey Kreutzer, Karl Y. Bilimoria

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Postoperative venous thromboembolism (VTE) is important clinically, and VTE quality metrics are used in public reporting and pay-for-performance programs. However, current VTE outcome measures are not valid due to surveillance bias, and the Surgical Care Improvement Project (SCIP-VTE-2) process measure only requires prophylaxis within 24 hours of surgery. Objectives: We sought to (1) develop a novel measure of VTE prophylaxis that requires early ambulation, mechanical prophylaxis, and chemoprophylaxis throughout the hospitalization, and (2) compare hospital performance on the SCIP-VTE-2 process measure to this novel measure. Research Design: A new composite measure of ambulation, sequential compression device (SCD), and chemoprophylaxis component measures was developed. The ambulation component required daily ambulation, the SCD component required documentation of continuous use, and the chemoprophylaxis component required patient-appropriate and medication-appropriate dosing and administration. Requirements could also be met with component-specific exceptions. Surgical patients at an academic center from 2012 to 2013 were assessed for SCIP-VTE-2 and composite measure adherence. Results: Of 786 patients, 589 (74.9%) passed the ambulation measure, 494 (62.8%) passed the SCD measure, and 678 (86.3%) passed the chemoprophylaxis measure. A total of 268 (91.8%) SCD failures and 46 (42.6%) chemoprophylaxis failures were ordered but not administered. When comparing the 2 measures, 784 (99.7%) passed SCIP-VTE-2, whereas only 364 (46.3%) passed the composite measure (P < 0.001). Conclusions: This new measure incorporates the critical aspects of VTE prevention to ensure defect-free care. After additional evaluation, this composite VTE prophylaxis measure with appropriate exclusion criteria may be a better alternative to existing VTE process and outcome measures.

Original languageEnglish (US)
Pages (from-to)210-217
Number of pages8
JournalMedical Care
Volume54
Issue number2
DOIs
StatePublished - 2016
Externally publishedYes

Fingerprint

Process Assessment (Health Care)
Venous Thromboembolism
Chemoprevention
Walking
Equipment and Supplies
Outcome Assessment (Health Care)
Incentive Reimbursement
Equipment Failure
Early Ambulation
Documentation
Hospitalization
Research Design

Keywords

  • Hospital compare
  • Postoperative complications
  • Process measure
  • Venous thromboembolism

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Medicine(all)

Cite this

Kinnier, C. V., Ju, M. H., Kmiecik, T., Barnard, C., Halverson, T., Yang, A. D., ... Bilimoria, K. Y. (2016). Development of a novel composite process measure for venous thromboembolism prophylaxis. Medical Care, 54(2), 210-217. https://doi.org/10.1097/MLR.0000000000000474

Development of a novel composite process measure for venous thromboembolism prophylaxis. / Kinnier, Christine V.; Ju, Mila H.; Kmiecik, Thomas; Barnard, Cindy; Halverson, Terri; Yang, Anthony D.; Caprini, Joseph; Kreutzer, Lindsey; Bilimoria, Karl Y.

In: Medical Care, Vol. 54, No. 2, 2016, p. 210-217.

Research output: Contribution to journalArticle

Kinnier, CV, Ju, MH, Kmiecik, T, Barnard, C, Halverson, T, Yang, AD, Caprini, J, Kreutzer, L & Bilimoria, KY 2016, 'Development of a novel composite process measure for venous thromboembolism prophylaxis', Medical Care, vol. 54, no. 2, pp. 210-217. https://doi.org/10.1097/MLR.0000000000000474
Kinnier, Christine V. ; Ju, Mila H. ; Kmiecik, Thomas ; Barnard, Cindy ; Halverson, Terri ; Yang, Anthony D. ; Caprini, Joseph ; Kreutzer, Lindsey ; Bilimoria, Karl Y. / Development of a novel composite process measure for venous thromboembolism prophylaxis. In: Medical Care. 2016 ; Vol. 54, No. 2. pp. 210-217.
@article{1002ea99b7bf43deaf422f2b6f9c5e8e,
title = "Development of a novel composite process measure for venous thromboembolism prophylaxis",
abstract = "Background: Postoperative venous thromboembolism (VTE) is important clinically, and VTE quality metrics are used in public reporting and pay-for-performance programs. However, current VTE outcome measures are not valid due to surveillance bias, and the Surgical Care Improvement Project (SCIP-VTE-2) process measure only requires prophylaxis within 24 hours of surgery. Objectives: We sought to (1) develop a novel measure of VTE prophylaxis that requires early ambulation, mechanical prophylaxis, and chemoprophylaxis throughout the hospitalization, and (2) compare hospital performance on the SCIP-VTE-2 process measure to this novel measure. Research Design: A new composite measure of ambulation, sequential compression device (SCD), and chemoprophylaxis component measures was developed. The ambulation component required daily ambulation, the SCD component required documentation of continuous use, and the chemoprophylaxis component required patient-appropriate and medication-appropriate dosing and administration. Requirements could also be met with component-specific exceptions. Surgical patients at an academic center from 2012 to 2013 were assessed for SCIP-VTE-2 and composite measure adherence. Results: Of 786 patients, 589 (74.9{\%}) passed the ambulation measure, 494 (62.8{\%}) passed the SCD measure, and 678 (86.3{\%}) passed the chemoprophylaxis measure. A total of 268 (91.8{\%}) SCD failures and 46 (42.6{\%}) chemoprophylaxis failures were ordered but not administered. When comparing the 2 measures, 784 (99.7{\%}) passed SCIP-VTE-2, whereas only 364 (46.3{\%}) passed the composite measure (P < 0.001). Conclusions: This new measure incorporates the critical aspects of VTE prevention to ensure defect-free care. After additional evaluation, this composite VTE prophylaxis measure with appropriate exclusion criteria may be a better alternative to existing VTE process and outcome measures.",
keywords = "Hospital compare, Postoperative complications, Process measure, Venous thromboembolism",
author = "Kinnier, {Christine V.} and Ju, {Mila H.} and Thomas Kmiecik and Cindy Barnard and Terri Halverson and Yang, {Anthony D.} and Joseph Caprini and Lindsey Kreutzer and Bilimoria, {Karl Y.}",
year = "2016",
doi = "10.1097/MLR.0000000000000474",
language = "English (US)",
volume = "54",
pages = "210--217",
journal = "Medical Care",
issn = "0025-7079",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Development of a novel composite process measure for venous thromboembolism prophylaxis

AU - Kinnier, Christine V.

AU - Ju, Mila H.

AU - Kmiecik, Thomas

AU - Barnard, Cindy

AU - Halverson, Terri

AU - Yang, Anthony D.

AU - Caprini, Joseph

AU - Kreutzer, Lindsey

AU - Bilimoria, Karl Y.

PY - 2016

Y1 - 2016

N2 - Background: Postoperative venous thromboembolism (VTE) is important clinically, and VTE quality metrics are used in public reporting and pay-for-performance programs. However, current VTE outcome measures are not valid due to surveillance bias, and the Surgical Care Improvement Project (SCIP-VTE-2) process measure only requires prophylaxis within 24 hours of surgery. Objectives: We sought to (1) develop a novel measure of VTE prophylaxis that requires early ambulation, mechanical prophylaxis, and chemoprophylaxis throughout the hospitalization, and (2) compare hospital performance on the SCIP-VTE-2 process measure to this novel measure. Research Design: A new composite measure of ambulation, sequential compression device (SCD), and chemoprophylaxis component measures was developed. The ambulation component required daily ambulation, the SCD component required documentation of continuous use, and the chemoprophylaxis component required patient-appropriate and medication-appropriate dosing and administration. Requirements could also be met with component-specific exceptions. Surgical patients at an academic center from 2012 to 2013 were assessed for SCIP-VTE-2 and composite measure adherence. Results: Of 786 patients, 589 (74.9%) passed the ambulation measure, 494 (62.8%) passed the SCD measure, and 678 (86.3%) passed the chemoprophylaxis measure. A total of 268 (91.8%) SCD failures and 46 (42.6%) chemoprophylaxis failures were ordered but not administered. When comparing the 2 measures, 784 (99.7%) passed SCIP-VTE-2, whereas only 364 (46.3%) passed the composite measure (P < 0.001). Conclusions: This new measure incorporates the critical aspects of VTE prevention to ensure defect-free care. After additional evaluation, this composite VTE prophylaxis measure with appropriate exclusion criteria may be a better alternative to existing VTE process and outcome measures.

AB - Background: Postoperative venous thromboembolism (VTE) is important clinically, and VTE quality metrics are used in public reporting and pay-for-performance programs. However, current VTE outcome measures are not valid due to surveillance bias, and the Surgical Care Improvement Project (SCIP-VTE-2) process measure only requires prophylaxis within 24 hours of surgery. Objectives: We sought to (1) develop a novel measure of VTE prophylaxis that requires early ambulation, mechanical prophylaxis, and chemoprophylaxis throughout the hospitalization, and (2) compare hospital performance on the SCIP-VTE-2 process measure to this novel measure. Research Design: A new composite measure of ambulation, sequential compression device (SCD), and chemoprophylaxis component measures was developed. The ambulation component required daily ambulation, the SCD component required documentation of continuous use, and the chemoprophylaxis component required patient-appropriate and medication-appropriate dosing and administration. Requirements could also be met with component-specific exceptions. Surgical patients at an academic center from 2012 to 2013 were assessed for SCIP-VTE-2 and composite measure adherence. Results: Of 786 patients, 589 (74.9%) passed the ambulation measure, 494 (62.8%) passed the SCD measure, and 678 (86.3%) passed the chemoprophylaxis measure. A total of 268 (91.8%) SCD failures and 46 (42.6%) chemoprophylaxis failures were ordered but not administered. When comparing the 2 measures, 784 (99.7%) passed SCIP-VTE-2, whereas only 364 (46.3%) passed the composite measure (P < 0.001). Conclusions: This new measure incorporates the critical aspects of VTE prevention to ensure defect-free care. After additional evaluation, this composite VTE prophylaxis measure with appropriate exclusion criteria may be a better alternative to existing VTE process and outcome measures.

KW - Hospital compare

KW - Postoperative complications

KW - Process measure

KW - Venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=84957845822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957845822&partnerID=8YFLogxK

U2 - 10.1097/MLR.0000000000000474

DO - 10.1097/MLR.0000000000000474

M3 - Article

C2 - 26683781

AN - SCOPUS:84957845822

VL - 54

SP - 210

EP - 217

JO - Medical Care

JF - Medical Care

SN - 0025-7079

IS - 2

ER -